Medication info
Duvimet SR 0.25/50/1000 mg

Duvimet SR 0.25/50/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletLobeglitazone Sulfate›0.25mg / 1 tabletSitagliptin Phosphate Hydrate›64.25mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Blue, biconvex, oval-shaped controlled-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202301433 · Approved 2023.05.02

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, the recommended dose of this medicine is lobeglitazone sulfate 0.5 mg and sitagliptin 100 mg; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 0.5/100/1000 mg extended-release tablet once daily. Patients taking this medicine 0.25/50/500 mg, 0.25/50/750 mg, or 0.25/50/1000 mg extended-release tablets should take 2 tablets together once daily. If adequate glycemic control cannot be achieved with metformin and sitagliptin, the starting dose of this medicine should be lobeglitazone sulfate 0.5 mg, sitagliptin 100mg, and the dose of metformin hydrochloride currently being taken, or an appropriate dose therapeutically equivalent to it. For patients switching from combination therapy with lobeglitazone, sitagliptin, and metformin to this medicine, the dose of this medicine should be the existing dose of each component. Since dose adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment [estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2]. 2. In patients with moderate renal impairment [CKD stage 3A, estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the metformin hydrochloride dose if it is well tolerated and there are no other conditions that may increase the risk of lactic acidosis. - Since the starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or estimated glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, administration of this medicine should be discontinued immediately.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in adult patients with type 2 diabetes. In particular, it is effective as an adjunct to diet and exercise therapy when used in combination with Rosiglitazone, Sitagliptin, and Metformin. This helps to effectively manage blood sugar levels and alleviate symptoms of diabetes.

How to take

Adult dose

For antidiabetic therapy, the recommended dose of this medicine is lobeglitazone sulfate 0.5 mg and sitagliptin 100 mg; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 0.5/100/1000 mg extended-release tablet once daily. Patients taking this medicine 0.25/50/500 mg, 0.25/50/750 mg, or 0.25/50/1000 mg extended-release tablets should take 2 tablets together once daily. If adequate glycemic control cannot be achieved with metformin and sitagliptin, the starting dose of this medicine should be lobeglitazone sulfate 0.5 mg, sitagliptin 100mg, and the dose of metformin hydrochloride currently being taken, or an appropriate dose therapeutically equivalent to it. For patients switching from combination therapy with lobeglitazone, sitagliptin, and metformin to this medicine, the dose of this medicine should be the existing dose of each component. Since dose adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment [estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2]. 2. In patients with moderate renal impairment [CKD stage 3A, estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the metformin hydrochloride dose if it is well tolerated and there are no other conditions that may increase the risk of lactic acidosis. - Since the starting dose of extended-release metformin hydrochloride is 500mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or estimated glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, administration of this medicine should be discontinued immediately.

Precautions

This medication may cause or exacerbate heart failure in patients with cardiac dysfunction, so it should be administered under thorough medical supervision. If symptoms of heart failure such as sudden weight gain, shortness of breath, or swelling occur, consult a healthcare professional immediately. It is advisable not to use this medication in patients with severe heart failure. Additionally, this medication may cause fluid retention, increasing the risk of heart failure, so caution is necessary. Some components of this medication may trigger allergic reactions, so it should be avoided in patients with hypersensitivity. Acute pancreatitis, a serious inflammation of the pancreas, may rarely occur; thus, report any symptoms such as abdominal pain, nausea, or vomiting to a doctor immediately. This medication can rarely cause serious metabolic disorders called lactic acidosis; seek medical attention if sudden fatigue, muscle pain, shortness of breath, or abdominal pain occur. It is not safe to use this medication in patients with impaired kidney function or liver dysfunction. Temporary discontinuation of the medication may be necessary before and after surgery, or in cases of severe infections or dehydration. Regular blood tests and monitoring of kidney and liver function are required during treatment, and any symptoms of weight gain, swelling, or shortness of breath should be communicated to healthcare professionals immediately. Moreover, this medication poses a risk of hypoglycemia, so care should be taken with irregular meals, intense exercise, or concurrent use with other hypoglycemic medications. Women who are pregnant or planning to become pregnant should consult a doctor before starting this medication. Alcohol intake should be avoided while on this medication, and if a dose is missed, patients should be cautious not to double the dose the next day. The use of this medication may decrease vitamin B12 levels in the body, necessitating regular testing and supplementation if needed. This medication has been reported to cause side effects such as blurred vision, macular edema, and increased fracture risk in some patients; therefore, consult a doctor if there are any eye issues or concerns about bone health. If severe joint pain or skin blisters occur during use, consult healthcare professionals immediately. This medication can enhance blood sugar control effects when used with other diabetes medications; however, it may also increase the risk of hypoglycemia, so vigilance is advised. Finally, strict dietary management and blood sugar monitoring should be adhered to, and any abnormal symptoms should be reported to a specialist immediately.

Side effects

  • Congestive heart failure
  • excessive and rapid weight change
  • shortness of breath
  • edema
  • severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • severe lactic acidosis
Show 193 more
  • hypoglycemia
  • nasopharyngitis
  • headache
  • dyspepsia
  • upper abdominal pain
  • edema
  • tinnitus
  • ligament sprain
  • hyperlipidemia
  • pruritus
  • osteoarthritis
  • myalgia
  • fracture
  • arthralgia
  • hematuria
  • increased ALT
  • increased AST
  • fatty liver
  • dizziness
  • sensory disturbances
  • diabetic retinopathy
  • palpitations
  • hypertension
  • anemia
  • herpes zoster
  • breast discomfort
  • constipation
  • chronic gastritis
  • gastroesophageal reflux disease
  • diabetic retinopathy
  • hyperglycemia
  • upper respiratory infection
  • cough
  • thirst
  • cold
  • weight gain
  • neck/shoulder pain
  • ligament disorder
  • ear ringing
  • insomnia
  • atherosclerosis
  • irritable bowel syndrome
  • colon polyps
  • peritonitis
  • gastroenteritis
  • bowel obstruction
  • appendicitis
  • pancreatitis exacerbation
  • kidney cancer
  • gallbladder carcinoma
  • gastric carcinoma
  • breast cancer
  • lung cancer
  • rib fracture
  • osteoporotic fracture
  • pelvic fracture
  • pneumonia
  • acute respiratory distress syndrome
  • asthma exacerbation
  • epiglottitis
  • surgical intervention
  • intervertebral disc disease
  • cholangitis
  • gallstones
  • hyperglycemia
  • increased blood glucose
  • brainstem infarction
  • syncope
  • subdural hematoma
  • acute renal failure
  • vomiting
  • gastrointestinal discomfort
  • gastroenteritis
  • oral ulcer formation
  • blood in stool
  • epigastric discomfort
  • loose stools
  • erosive gastritis
  • esophagitis
  • dysphagia exacerbation
  • gastric ulcer
  • oral ulcer formation
  • gingivitis
  • periodontitis
  • hemorrhoids
  • hemorrhoids exacerbation
  • toothache
  • exacerbation of hypercholesterolemia
  • increased fasting blood glucose levels
  • increased glycosylated hemoglobin
  • vitamin D deficiency
  • dyslipidemia
  • increased low-density lipoprotein
  • weight loss
  • gout
  • elevated blood cholesterol
  • pelvic pain
  • periorbital edema
  • exacerbated edema
  • flank pain
  • back pain
  • generalized edema
  • generalized weakness
  • leg edema
  • lack of efficacy
  • periorbital edema
  • acute respiratory distress syndrome
  • bronchitis
  • chronic obstructive pulmonary disease
  • chronic laryngitis
  • throat infection
  • atelectasis
  • sinusitis
  • breathlessness
  • asthma exacerbation
  • nosebleeds
  • shortness of breath
  • pulmonary edema
  • epiglottitis
  • polyneuropathy
  • cognitive impairment
  • skin tingling
  • eyelid twitching
  • leg cramps
  • simple partial seizure
  • peripheral sensory neuropathy
  • dysphonia
  • exacerbated dizziness
  • spinal canal stenosis
  • cystitis
  • nocturia
  • increased serum creatinine
  • dysuria
  • frequent urination
  • nephrotic syndrome
  • ureteral stones
  • urinary tract infection
  • shoulder girdle syndrome
  • costochondritis
  • leg fracture
  • temporomandibular joint dysfunction
  • elbow deformity
  • tinea corporis
  • keratosis
  • psoriasis
  • exacerbation of psoriasis
  • acute urticaria
  • vitiligo
  • trichomycosis
  • onychomycosis
  • hair loss
  • skin nodules
  • skin peeling
  • dermatosis
  • erythematous rash
  • corneal deposits
  • conjunctivitis
  • ocular hypertension
  • lacrimal duct obstruction
  • chorioretinal disorders
  • cataract
  • exacerbation of cataract
  • decreased vision
  • eye infection
  • epidermoid cyst
  • erythrocytosis
  • erectile dysfunction
  • anxiety reaction
  • depression
  • low mood
  • mental disorders
  • confusion
  • skin tearing
  • knee joint arthroplasty
  • herniated disc
  • dry eye syndrome
  • toxocariasis
  • genital moniliasis
  • vulvovaginal candidiasis
  • increased TSH
  • hyperthyroidism
  • sialoadenitis
  • vaginitis
  • cervical dysplasia
  • menopausal symptoms
  • intermittent claudication
  • aortic atherosclerosis
  • coronary artery occlusion
  • male perineal pain
  • atrial fibrillation
  • ventricular premature contraction
  • discoid lupus erythematosus
  • bruising

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The ambient temperature should be maintained between 1 and 30 degrees Celsius. This will help to preserve the effectiveness of the medication for a longer time and ensure safe usage.

Appearance and packaging

Appearance

Blue, biconvex, oval-shaped controlled-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.